KRO · Kronos Worldwide Inc
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| EBITDA non-GAAP | $80.6M | Six months ended June 30, 2026 | — |
| Production volumes | 263K | Six months ended June 30, 2026 | — |
| Sales volumes | 295K | Six months ended June 30, 2026 | — |
| TiO2 segment profit non-GAAP | $56.1M | Six months ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KRO
this stock
Kronos Worldwide Inc
|
$895.46M | +76.0% | -1.5% | — | 0.9% |
|
LIN
Linde PLC
|
$223.11B | +13.5% | +3.0% | 31.2 | 1.3% |
|
AIQUF
L Air Liquide SA /Fi
|
$120.27B | +0.4% | — | — | 0.0% |
|
ECL
Ecolab Inc.
|
$77.67B | +5.9% | +2.2% | 37.2 | 1.9% |
|
SHW
Sherwin Williams Co
|
$76.47B | -2.8% | +2.1% | 29.1 | 2.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KRO | +1.7% | -8.0% | +22.9% | +1.7% | +76.0% |
| SPY | +1.9% | +1.9% | +10.8% | +1.9% | +14.0% |
| vs SPY | -0.2% | -10.0% | +12.1% | -0.2% | +62.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.